A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Clinical trial NCT06233461 · RECRUITING

Trial details

NCT number: NCT06233461
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2024-03-05
Primary completion: 2026-09-18
Enrollment: 268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.